Colony-stimulating factor priming for collection of peripheral blood stem cells.
This article is an executive summary of the Blue Cross Blue Shield Technology Evaluation Center (TEC) Assessment "Colony-Stimulating Factor Priming for Collection of Peripheral Blood Stem Cells," Volume 9, No. 21, 1994. The complete assessment, which includes background information, methods, formulation of the assessment, review of evidence, conclusions, and references are available to Blue Cross Blue Shield TEC Program subscribers only.  For subscription information, contact the program at (312) 440-6080.
D054598:Blue Cross Blue Shield Insurance Plans; D005069:Evaluation Studies as Topic; D016179:Granulocyte Colony-Stimulating Factor / Q000627:therapeutic use; D016178:Granulocyte-Macrophage Colony-Stimulating Factor / Q000627:therapeutic use; D018380:Hematopoietic Stem Cell Transplantation; D006801:Humans; D017063:Outcome Assessment, Health Care; D013673:Technology Assessment, Biomedical; D014182:Transplantation, Autologous; D014481:United States; D014486:United States Food and Drug Administration